Biography
Dr Zhao Yi Jing is a Singapore trained and certified Clinical Neurologist. She completed her medical degree training from the National University of Singapore with a MBBS degree. Thereafter, she became a member of the Royal College of Physicians (MRCP), and was also awarded the Masters of Medicine by National University of Singapore (NUS). She started her neurology career practicing in Singapore General Hospital (SGH), National Neuroscience Institute (NNI). She was a visiting Neurology Consultant to Khoo Teck Puat Hospital (KTPH), Sengkang General Hospital (SKH) and Changi General Hospital (CGH). She was also a clinical lecturer in Lee Kong Chian School of Medicine, Yong Loo Lin School of Medicine and a Clinical Assistant Professor in Duke-NUS Medical School.
Professional Excellence and Expertise
Dr Zhao was a visiting neurology consultant at Khoo Teck Puat Hospital, Sengkang General Hospital and Changi General Hospital. She is a member of the Asian Regional Consortium Headache Society, Singapore Medical Council and Singapore Medical Association. She was also part of the founding committee of the Headache Society of Singapore, and is currently the vice-president and treasurer. She has conducted talks in regional headache meetings and has sat on the advisory board for new treatments in headache and migraine.
Clinical Expertise and Special Interest
Dr Zhao's subspecialty interest is in headaches, including headaches in adults, adolescents and pregnancy. She also treats neurological conditions such as sleep-related issues, stroke, Parkinson's disease, epilepsy, motor neuron disease, dementia and other neurological conditions. Besides her clinical work, she was a clinical lecturer at Lee Kong Chian School of Medicine and Yong Loo Lin School of Medicine, and a clinical assistant professor at Duke-NUS Medical School.
Contributions to the Field
Dr Zhao has published research papers on headache conditions, including the novel calcitonin gene- related peptide (CGRP) therapies for headache and migraine. She served as the Singapore principal investigator in several regional clinical trials for the latest headache treatment using CGRP monoclonal antibodies and small molecules.
